Invivoscribe

Name: Invivoscribe
Address: 10222 Barnes Canyon Road , Building 1, San Diego, CA, 92121, US
Telephone: +18582246600

Call Directions Website Contact the business

Improving lives with precision diagnostic products & services to improve patient outcomes worldwide.

10/18/2026

Join the conversation at ASHG 2026! Working in computational genomics, immune repertoire analysis, or clinical translational research? Our team is presenting a poster in Montréal and we would love to talk through the data with you: "Evaluation of LymphoTrack® Enterprise Software for Quantitative MRD, CLL Subset Classification, and Ig/TCR Repertoire Diversity Analysis"

📆Wednesday, October 21, 2026 at 2:30 PM
📍Board 2032W, Exhibit & Poster Hall
🔬Laboratory Genetics and Genomics Poster session

Excited to connect with you at !

10/15/2026

Moving from PCR to NGS for MRD isn't only about switching platforms. It also changes how you validate, how you set your limit of detection, and how you choose clonal markers.

In our upcoming webinar, Dr. Svea Stratmann and Alice Scarpa cover the practical side of that transition:
✅ Establishing limit of detection and analytical sensitivity
✅ Assessing baseline clonality and somatic hypermutation in CLL, ALL, multiple myeloma and lymphomas
✅ Selecting IG/TCR rearrangements for MRD across lymphoid malignancies

If your lab is planning or expanding NGS-based MRD assessment, this session will give you a realistic roadmap.

📅 October 28, 2026
🕰️ 10 am PST | 1 pm EST | 6 pm CEST

Save your spot: https://na2.hubs.ly/H08n_qw0

10/14/2026

Heading to 2026 in Montréal, October 20–24? Let's connect!

The team is heading to the Palais des Congrès to join the conversations shaping the future of human genetics.

Catch our poster and learn how ® Enterprise Software brings automated, high-throughput analysis to our B- and T-cell clonality assays. “Evaluation of LymphoTrack® Enterprise Software for Quantitative MRD, CLL Subset Classification, and Ig/TCR Repertoire Diversity Analysis”

📆Wednesday, October 21, 2026 at 2:30 PM
📍Board 2032W, Exhibit & Poster Hall
🔬Laboratory Genetics and Genomics Poster session

See you in Montréal!

10/13/2026

Introducing 𝗟𝘆𝗺𝗽𝗵𝗼𝗧𝗿𝗮𝗰𝗸® 𝗙𝗹𝗲𝘅 Assays which were built to give labs more control over high-sensitivity lymphoid testing, without compromising speed or accuracy.

Bring clonality, SHM, and ultra-high sensitivity (UHS) NGS testing in-house to achieve faster turnaround times, greater visibility into your results, and confidence in the sensitivity you need.

Designed for real-world laboratory workflows, 𝗟𝘆𝗺𝗽𝗵𝗼𝗧𝗿𝗮𝗰𝗸® 𝗙𝗹𝗲𝘅 is:
• 𝗙𝗹𝗲𝘅𝗶𝗯𝗹𝗲 across a range of DNA input amounts for UHS-NGS
• 𝗦𝗰𝗮𝗹𝗮𝗯𝗹𝗲 design enabling labs to multiplex samples in a sequencing run and adjust batch sizes for their workflow, capacity, and testing demand
• 𝗔𝘂𝘁𝗼𝗺𝗮𝘁𝗶𝗼𝗻-𝗿𝗲𝗮𝗱𝘆 for high-throughput standardized testing workflows
• 𝗙𝗮𝘀𝘁 𝗧𝘂𝗿𝗻-𝗔𝗿𝗼𝘂𝗻𝗱 𝗧𝗶𝗺𝗲𝘀 with results in < 50 hours
• 𝗔𝗰𝗰𝘂𝗿𝗮𝘁𝗲, objective sequence-level information for each result
•𝗧𝗿𝗮𝗻𝘀𝗽𝗮𝗿𝗲𝗻𝘁 results through testing performed in-house with direct oversight

The result: a more flexible path to in-house clonality, SHM and MRD testing enabling better control, faster TAT, and greater confidence in detecting and assessing ultra-low levels of disease.

Learn more about 𝗟𝘆𝗺𝗽𝗵𝗼𝗧𝗿𝗮𝗰𝗸® 𝗙𝗹𝗲𝘅: https://na2.hubs.ly/H08kmSt0

10/12/2026

Good things are brewing... ☕Invivoscribe is heading to Seattle for !

📍 Visit us at 𝗯𝗼𝗼𝘁𝗵 #𝟲𝟯𝟳 to talk molecular pathology, from sample preparation to ultra-high sensitivity MRD.

⚙️𝗝𝗼𝗶𝗻 𝗼𝘂𝗿 𝘄𝗼𝗿𝗸𝘀𝗵𝗼𝗽
Tahoma 1, Level 2, Arch at 800 Pike
Wednesday, November 11th | 4:00 –5:00 PM

📊𝗖𝗮𝘁𝗰𝗵 𝗼𝘂𝗿 𝗽𝗼𝘀𝘁𝗲𝗿𝘀!
📃𝗣𝗼𝘀𝘁𝗲𝗿 #𝗧𝗧𝟬𝟮𝟯 - Friday, November 13th | 9:15- 10:15 AM
📃𝗣𝗼𝘀𝘁𝗲𝗿 #𝗧𝗧𝟬𝟮𝟱 – Saturday, November 14th | 9:15 –10:15 AM
📃𝗣𝗼𝘀𝘁𝗲𝗿 #𝗧𝗧𝟬𝟯𝟭 - Saturday, November 14th | 9:15 –10:15 AM
📃𝗣𝗼𝘀𝘁𝗲𝗿 # 𝗧𝗧𝟬𝟭𝟵 - Saturday, November 14th | 9:15 –10:15 AM

We can't wait to see you in Seattle!

10/08/2026

Clonality and MRD assessment in lymphoid malignancies are only as good as their sensitivity. Is your lab ready to move beyond PCR and take the next step with NGS?

Join us for A Practical Path to NGS: Clonality and Ultra-High Sensitivity MRD Assessment in Lymphoid Malignancies. October 28, 2026, 10 am PST | 1 pm EST | 6 pm CEST

Dr. Svea Stratmann will share what she learned implementing ultra-high sensitivity NGS (UHS-NGS) for routine clonality assessment in ALL and CLL. Alice Scarpa will share practical insights into implementing NGS-based MRD workflows, from analytical validation and marker selection to post-transplant research applications.

Learn about:
🔹 Validating workflows and establishing analytical performance
🔹 Selecting the right IG/TCR markers for MRD
🔹 Moving from PCR-based methods to NGS

Built for molecular pathologists, hematopathologists, lab directors, and lab teams expanding their NGS capabilities.

Register here: https://na2.hubs.ly/H08hb0G0

10/07/2026

That's a wrap on ! Thank you to everyone who stopped by booth #405 in Miami to talk Flow with our team.

It was great to have Dr. Hong Drum, Medical Director at , on site sharing her expertise in flow-based diagnosis and monitoring. A big thank you to the ICCS organizers and the clinical cytometry community for an energizing few days of science and connection.

Missed us in Miami? Explore our globally standardized MFC assays:
👉 Hematolymphoid Screening Panel
👉AML MRD Assay
👉CLL MRD Assay

Built for the sensitivity, specificity, and reproducibility labs need for accurate diagnosis, prognostication, and risk stratification.

Let's keep the conversation going: https://na2.hubs.ly/H08fsf30

10/06/2026

Objective clonality assessments and ultra-high sensitivity MRD, in one NGS workflow.

Today, we're announcing the launch of the complete LymphoTrack® Flex suite which brings seven immunoglobulin and TCR targets together in one automation-friendly workflow. High-throughput laboratories can now implement flexible, scalable testing for , somatic hypermutation, and sequence-based analyses across a broad range of lymphoid malignancies.

"Our vision is to give all laboratories access to optimized MRD assays, controls, and interpretive software, with one standardized approach." – Jeff Miller, CEO, Invivoscribe

Read the full press release: https://na2.hubs.ly/H08c_Ht0

10/05/2026

We’re still at in Berlin today and tomorrow 👋

Stop by the Invivoscribe booth to meet the team and learn more about ultra-high sensitivity molecular testing solutions for AML, CLL, ALL, lymphoma, and multiple myeloma.

We’re showcasing globally standardized testing for clonal rearrangements, FLT3 ITD, NPM1, and KMT2A, along with the fully automated ™ System, designed to support consistent, standardized molecular workflows.

Learn about PrepQuant ahead of its European launch in early 2027: https://na2.hubs.ly/H08bg5h0

10/04/2026

We’re at in Berlin.

Stop by Invivoscribe Booth #1 to meet the team and learn more about ultrasensitive molecular testing solutions for AML, CLL, ALL, lymphoma, and multiple myeloma. We'll be showcasing globally standardized testing for clonal rearrangements, FLT3 ITD, NPM1, and KMT2A, along with the fully automated ™ System, built to help laboratories deliver consistent, actionable molecular results.

Preview PrepQuant ahead of its European launch in early 2027: https://na2.hubs.ly/H089PQB0

European Association for Haematopathology

Address

10222 Barnes Canyon Road , Building 1
San Diego, CA
92121

Telephone

+18582246600

Website

http://www.invivoscribe.com/

Alerts

Be the first to know and let us send you an email when Invivoscribe posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Invivoscribe:

Want your business to be the top-listed business in San Diego?